Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma

Puntos clave

• Serum procalcitonin serves as a promising tumor biomarker for diagnosing fibrolamellar hepatocellular carcinoma.
• Key evidence indicates that elevated serum procalcitonin levels correlate significantly with disease presence.
• Observational analysis evaluating serum levels of procalcitonin in patients diagnosed with fibrolamellar hepatocellular carcinoma.
• Findings underscore the potential of serum procalcitonin in monitoring disease progression and treatment response.